|
AXSM Axsome Therapeutics Inc 1579428 |
| Balance Sheet |
|
Current Assets
|
$611,206,000.00 |
|
Assets
|
$713,607,000.00 |
|
Current Liabilities
|
$439,211,000.00 |
|
Liabilities
|
$659,020,000.00 |
|
Equity
|
$54,587,000.00 |
|
Shares Out
|
51420445.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-20,700,000.00 |
|
Investing Cash Flow
|
$-121,000.00 |
| Market Analysis |
Market Cap
|
$12,065,293,214.80 |
|
Price
|
$211.46 |
|
BVPS
|
1.06 |
|
PB
|
221.36 |
|
EPS
|
-1.26 |
|
PS
|
16.43 |
|
FCF
|
$-20,821,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:16 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:09 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-23 |
-0.56 |
|
| Apr |
May |
Jun |
|
|
|
|
2026-05-04 |
-1.26 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-04 |
-0.97 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-03 |
-0.94 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view AXSM documents filed with the SEC.
AXSM Filings
Clear
